Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Journavx pharmaceutical company?

See the DrugPatentWatch profile for Journavx

Journavx is the brand name for eluxadoline, a drug used for irritable bowel syndrome with diarrhea (IBS-D). The pharmaceutical company behind Journavx is Phathom Pharmaceuticals.

Who makes Journavx?

Phathom Pharmaceuticals is the company that markets Journavx (eluxadoline).[1]

What is Journavx used for?

Journavx (eluxadoline) is prescribed for IBS-D (irritable bowel syndrome with diarrhea).[1]

Is there information on patents or exclusivity for Journavx?

DrugPatentWatch.com tracks patent and exclusivity activity for branded drugs like Journavx and can be used to look up relevant filings and timelines.[2]

Sources

[1] https://www.drugs.com/mtm/journavx.html
[2] https://www.drugpatentwatch.com/



Other Questions About Journavx :

achat journavx en europe Journavx return on investment for hospitals? Journavx™? Journavx pricing and coverage policies trends? Journavx europe? Journavx patent? What factors influence the price of journavx per dose?